144 related articles for article (PubMed ID: 12809924)
1. Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases.
Patel Y; Mitchell CD; Hitchcock RJ
Urology; 2003 Jun; 61(6):1260. PubMed ID: 12809924
[TBL] [Abstract][Full Text] [Related]
2. Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy.
Loeb DM; Hill DA; Dome JS
J Pediatr Hematol Oncol; 2002; 24(6):478-81. PubMed ID: 12218597
[TBL] [Abstract][Full Text] [Related]
3. Congenital mesoblastic nephroma metastatic to the brain: a report of two cases.
Schlesinger AE; Rosenfield NS; Castle VP; Jasty R
Pediatr Radiol; 1995 Nov; 25 Suppl 1():S73-5. PubMed ID: 8577561
[TBL] [Abstract][Full Text] [Related]
4. [Successful therapy of local recurrence of congenital mesoblastic nephroma].
Dickerhoff R; Weirich A; Harms D; Schmidt D
Klin Padiatr; 1995; 207(2):48-51. PubMed ID: 7752599
[TBL] [Abstract][Full Text] [Related]
5. Preoperative chemotherapy of cellular congenital mesoblastic nephroma in a 5-month-old infant.
Stalens JP; Gosseye S; Clapuyt P; Ninane J
Pediatr Hematol Oncol; 1992; 9(4):335-45. PubMed ID: 1281666
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemotherapy for mesoblastic nephroma.
Chan KL; Chan KW; Lee CW; Saing H
Med Pediatr Oncol; 1995 Apr; 24(4):271-3. PubMed ID: 7700175
[TBL] [Abstract][Full Text] [Related]
7. [Atypical mesoblastic nephroma with metastases right away?].
Fallouh K; Delarue A; Petit P; Chrestian MA; Portas M; Horschowski N; Bernard JL
Bull Cancer; 1997 Aug; 84(8):807-12. PubMed ID: 9339186
[TBL] [Abstract][Full Text] [Related]
8. Congenital mesoblastic nephroma with metastasis to the brain: a case report.
Ali AA; Finlay JL; Gerald WL; Nisen P; Rosenfield NS; LaQuaglia MP; Spillman M; O'Mally B; Fraser R
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):361-4. PubMed ID: 7978057
[No Abstract] [Full Text] [Related]
9. Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma.
Halalsheh H; McCarville MB; Neel M; Reynolds M; Cox MC; Pappo AS
Pediatr Blood Cancer; 2018 Oct; 65(10):e27271. PubMed ID: 29893456
[TBL] [Abstract][Full Text] [Related]
10. [Congenital mesoblastic nephroma].
Skorić D; Bunjevacki G; Sćepanović D; Sindzić M
Srp Arh Celok Lek; 1993; 121(1-2):41-4. PubMed ID: 8202824
[TBL] [Abstract][Full Text] [Related]
11. Congenital mesoblastic nephroma metastatic to the brain.
Heidelberger KP; Ritchey ML; Dauser RC; McKeever PE; Beckwith JB
Cancer; 1993 Oct; 72(8):2499-502. PubMed ID: 8402467
[TBL] [Abstract][Full Text] [Related]
12. Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
Richey SL; Rao P; Wood CG; Patel S; Tannir NM
Clin Genitourin Cancer; 2012 Sep; 10(3):210-2. PubMed ID: 22503609
[No Abstract] [Full Text] [Related]
13. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
14. Atypical mesoblastic nephroma. A potentially malignant variant of congenital mesoblastic nephroma. Review of literature & report of four cases.
Sane SY; Badhe PB; Kulkarni BK
Indian J Cancer; 1996 Mar; 33(1):6-11. PubMed ID: 9063011
[TBL] [Abstract][Full Text] [Related]
15. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
[TBL] [Abstract][Full Text] [Related]
16. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.
McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR
Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616
[TBL] [Abstract][Full Text] [Related]
17. Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Kuperman AA; Kornreich L; Feinmesser M; Ash S; Yaniv I; Cohen IJ
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e25-6. PubMed ID: 22935658
[TBL] [Abstract][Full Text] [Related]
18. [A case of congenital mesoblastic nephroma in adulthood].
Yamashita A; Yasuda M; Sugita O; Yamashita M; Shuin T
Hinyokika Kiyo; 1998 Jun; 44(6):411-4. PubMed ID: 9719941
[TBL] [Abstract][Full Text] [Related]
19. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
20. Classical congenital mesoblastic nephroma in an adult: a case report on an Ethiopian.
Gemechu T; Bezabeh K
Ethiop Med J; 1997 Oct; 35(4):257-62. PubMed ID: 10214440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
